These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30178246)

  • 1. Epigenome-Based Precision Medicine in Lung Cancer.
    Kim D; Kim DH
    Methods Mol Biol; 2018; 1856():57-85. PubMed ID: 30178246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
    Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
    Shea M; Costa DB; Rangachari D
    Ther Adv Respir Dis; 2016 Apr; 10(2):113-29. PubMed ID: 26620497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can sensitivity to cytotoxic chemotherapy be predicted by biomarkers?
    Felip E; Martinez P
    Ann Oncol; 2012 Sep; 23 Suppl 10():x189-92. PubMed ID: 22987959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Potential Epigenetic Therapy for NSCLC.
    Cancer Discov; 2015 Apr; 5(4):341. PubMed ID: 25724377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer.
    Forde PM; Brahmer JR; Kelly RJ
    Clin Cancer Res; 2014 May; 20(9):2244-8. PubMed ID: 24644000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successes and limitations of targeted cancer therapy in lung cancer.
    Suda K; Mitsudomi T
    Prog Tumor Res; 2014; 41():62-77. PubMed ID: 24727987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
    Juergens RA; Rudin CM
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted agents in the management of small cell lung cancer - present and future.
    Srivastava R; Lebowicz Y; Jamil MO
    Drugs Today (Barc); 2018 Aug; 54(8):479-488. PubMed ID: 30209442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in non-small cell lung cancer: from basics to therapeutics.
    Ansari J; Shackelford RE; El-Osta H
    Transl Lung Cancer Res; 2016 Apr; 5(2):155-71. PubMed ID: 27186511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in Personalized Management of Lung Cancer.
    Ahmad A
    Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome.
    Tellez CS; Grimes MJ; Picchi MA; Liu Y; March TH; Reed MD; Oganesian A; Taverna P; Belinsky SA
    Int J Cancer; 2014 Nov; 135(9):2223-31. PubMed ID: 24668305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.
    Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R
    Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Therapy of Non-small Cell Lung Cancer (NSCLC).
    Gadgeel SM
    Adv Exp Med Biol; 2016; 890():203-22. PubMed ID: 26703806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
    Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
    Drug Resist Updat; 2011 Dec; 14(6):280-96. PubMed ID: 21955833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine.
    Lomberk G; Dusetti N; Iovanna J; Urrutia R
    Nat Commun; 2019 Aug; 10(1):3875. PubMed ID: 31462645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer genotype-based therapy and predictive biomarkers: present and future.
    Cagle PT; Allen TC
    Arch Pathol Lab Med; 2012 Dec; 136(12):1482-91. PubMed ID: 23194040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
    Albaba H; Lim C; Leighl NB
    Pharmacoeconomics; 2017 Dec; 35(12):1195-1209. PubMed ID: 28861770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.